Swiss National Bank
BEAT

Swiss National Bank’s BioTelemetry, Inc. BEAT Stock Holding History

Swiss National Bank’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-77,400
Closed -$5.58M – 2500
2020
Q4 		$5.58M Hold
77,400
– – ﹤0.01% 1298
2020
Q3 		$3.53M Buy
77,400
+1,600
+2% +$66.9K ﹤0.01% 1402
2020
Q2 		$3.42M Buy
75,800
+9,900
+15% +$444K ﹤0.01% 1379
2020
Q1 		$2.54M Buy
65,900
+1,000
+2% +$46K ﹤0.01% 1310
2019
Q4 		$3M Buy
64,900
+1,600
+3% +$69.3K ﹤0.01% 1489
2019
Q3 		$2.58M Buy
63,300
+800
+1% +$34.5K ﹤0.01% 1509
2019
Q2 		$3.01M Buy
62,500
+1,800
+3% +$94.6K ﹤0.01% 1440
2019
Q1 		$3.8M Buy
60,700
+2,800
+5% +$192K ﹤0.01% 1261
2018
Q4 		$3.46M Buy
57,900
+1,300
+2% +$78.1K ﹤0.01% 1204
2018
Q3 		$3.65M Hold
56,600
– – ﹤0.01% 1328
2018
Q2 		$2.55M Buy
56,600
+3,000
+6% +$120K ﹤0.01% 1547
2018
Q1 		$1.66M Buy
53,600
+2,800
+6% +$92.1K ﹤0.01% 1761
2017
Q4 		$1.52M Hold
50,800
– – ﹤0.01% 1820
2017
Q3 		$1.68M Buy
50,800
+7,000
+16% +$242K ﹤0.01% 1729
2017
Q2 		$1.47M Hold
43,800
– – ﹤0.01% 1783
2017
Q1 		$1.27M Hold
43,800
– – ﹤0.01% 1862
2016
Q4 		$979K Buy
+43,800
New +$856K ﹤0.01% 2048

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Swiss National Bank's BEAT Position: Q1 2021 in Review

Swiss National Bank sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 77,400 shares — an estimated $5.58M sold.

Swiss National Bank first reported a position in BEAT in Q4 2016 and held it in 17 quarters. The position peaked at $5.58M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Swiss National Bank reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Swiss National Bank sold 77,400 BioTelemetry, Inc. shares in Q1 2021, an estimated $5.58M.
  • Swiss National Bank first reported a position in BioTelemetry, Inc. in Q4 2016 and held it in 17 quarters.
  • Swiss National Bank's BioTelemetry, Inc. position peaked at $5.58M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.